These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1302216)

  • 41. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
    Schmiegel WH; Kalthoff H
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
    [No Abstract]   [Full Text] [Related]  

  • 42. [Visualization of malignant tumors in the abdomen using radiolabelled monoclonal antibodies].
    Pateisky N; Philipp K; Burchell J; Skodler W
    Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):623-6. PubMed ID: 6097499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiolabelled monoclonal antibodies in tumour diagnosis and therapy.
    Kosmas C; Kalofonos HP; Epenetos AA
    Dev Biol Stand; 1990; 71():93-102. PubMed ID: 2401391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Production and identification of a monoclonal antibody against a tumor associated antigen from ovarian epithelial carcinoma].
    Gong GL; Zou JY; Cai ZT
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):395-7, 443-4. PubMed ID: 8001414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possibility of immunodiagnosis in ovarian cancer.
    Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
    [No Abstract]   [Full Text] [Related]  

  • 46. Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.
    Pedley RB; Boxer GM; Boden JA; Southall PJ; Begent RH; Bagshawe KD; Humm J; Searle F
    Br J Cancer; 1990 Feb; 61(2):218-20. PubMed ID: 2310674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Radioimmunotherapy in patients with ovarian cancer in complete remission after the first line surgery and chemotherapy after second look laparoscopy procedure].
    Markowska J; Madry R; Kierzkowski J; Malicki J; Roszak A; Lubin J; Bratos K
    Ginekol Pol; 2003 Sep; 74(9):799-804. PubMed ID: 14674127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preparation and characterization of a monoclonal antibody reactive with human ovarian serous cystadenocarcinoma].
    Ookura N
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):47-58. PubMed ID: 2440966
    [No Abstract]   [Full Text] [Related]  

  • 49. [Isolated rise of CA 15-3 marker revealing an ovarian metastasis of breast cancer].
    Levy V; Morere JF; Israel L; Courtinot B; Boaziz C; Breau JL
    Presse Med; 1990 May; 19(20):967-8. PubMed ID: 2141138
    [No Abstract]   [Full Text] [Related]  

  • 50. An unusual evolution of the serum CA 125 level in a ovarian cancer patient.
    Huys J; Vereecke C; De Sutter L; Troch M
    Gynecol Oncol; 1993 May; 49(2):259-61. PubMed ID: 8504997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells.
    Kunimatsu M; Endo K; Nakashima T; Awaji T; Saga T; Watanabe Y; Kawamura Y; Ohta H; Koizumi M; Sakahara H
    Ann Nucl Med; 1988 Nov; 2(2):73-9. PubMed ID: 3275111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human ovarian cancers specifically bind daunorubicin-OC-125 conjugate: an immunofluorescence study.
    Dezsö B; Török I; Rosik LO; Sweet F
    Gynecol Oncol; 1990 Oct; 39(1):60-4. PubMed ID: 2227573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of 131I-labelled anti-CEA/CA 19-9 monoclonal antibodies in the diagnosis and follow-up of gastrointestinal tumors.
    Giordano A; Rufini V; Campioni P; Vaccaro A; Troncone L
    Int J Rad Appl Instrum B; 1989; 16(2):151. PubMed ID: 2715009
    [No Abstract]   [Full Text] [Related]  

  • 54. Megavoltage radiation therapy and lymphangiography in ovarian cancer.
    Hanks GE; Bagshaw MA
    Radiology; 1969 Sep; 93(3):649-54. PubMed ID: 4309819
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunoscintigraphy of oncologic tumors].
    Barzen G
    Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [REGAJ diagnosis of recurrence of ovarian cancer].
    Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
    Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
    [No Abstract]   [Full Text] [Related]  

  • 57. Heterogeneity of antigen expression in advanced epithelial ovarian cancer.
    Berchuck A; Olt GJ; Soisson AP; Kamel A; Soper JT; Boyer CM; Clarke-Pearson DL; Leslie DS; Bast RC
    Am J Obstet Gynecol; 1990 Apr; 162(4):883-8. PubMed ID: 2327461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
    Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
    Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.
    Epenetos AA; Munro AJ; Stewart S; Rampling R; Lambert HE; McKenzie CG; Soutter P; Rahemtulla A; Hooker G; Sivolapenko GB
    J Clin Oncol; 1987 Dec; 5(12):1890-9. PubMed ID: 3681374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas.
    Henzen-Logmans SC; Schipper NW; Poels LG; Stolk K; Kenemans P; Meyer CJ
    J Clin Pathol; 1988 Jun; 41(6):644-9. PubMed ID: 3384998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.